ZA200408423B - Novel tetrahydropyridine derivatives as renin inhibitors. - Google Patents

Novel tetrahydropyridine derivatives as renin inhibitors.

Info

Publication number
ZA200408423B
ZA200408423B ZA200408423A ZA200408423A ZA200408423B ZA 200408423 B ZA200408423 B ZA 200408423B ZA 200408423 A ZA200408423 A ZA 200408423A ZA 200408423 A ZA200408423 A ZA 200408423A ZA 200408423 B ZA200408423 B ZA 200408423B
Authority
ZA
South Africa
Prior art keywords
renin inhibitors
tetrahydropyridine derivatives
novel tetrahydropyridine
novel
derivatives
Prior art date
Application number
ZA200408423A
Other languages
English (en)
Inventor
Olivier Bezencon
Walter Fischli
Sylvia Richard-Bildstein
Daniel Bur
Lubos Remen
Thomas Weller
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of ZA200408423B publication Critical patent/ZA200408423B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200408423A 2002-06-27 2004-10-18 Novel tetrahydropyridine derivatives as renin inhibitors. ZA200408423B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0207102 2002-06-27

Publications (1)

Publication Number Publication Date
ZA200408423B true ZA200408423B (en) 2005-10-11

Family

ID=29797098

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200408423A ZA200408423B (en) 2002-06-27 2004-10-18 Novel tetrahydropyridine derivatives as renin inhibitors.

Country Status (16)

Country Link
US (1) US20060009497A1 (de)
EP (1) EP1519920A1 (de)
JP (1) JP2005532371A (de)
CN (1) CN1662498A (de)
AU (1) AU2003229746A1 (de)
BR (1) BR0312000A (de)
CA (1) CA2490138A1 (de)
CL (1) CL2003002043A1 (de)
IL (1) IL165887A0 (de)
MX (1) MXPA04012136A (de)
NO (1) NO20050290L (de)
PL (1) PL375214A1 (de)
RU (1) RU2005102002A (de)
TW (1) TW200514772A (de)
WO (1) WO2004002957A1 (de)
ZA (1) ZA200408423B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1780836A (zh) * 2003-04-28 2006-05-31 埃科特莱茵药品有限公司 作为血管紧张肽原酶抑制剂的新型二氮杂双环壬烯和四氢吡啶衍生物
CA2521932A1 (en) * 2003-04-29 2004-11-11 Actelion Pharmaceuticals Ltd Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
CN1780663A (zh) * 2003-04-30 2006-05-31 埃科特莱茵药品有限公司 作为肾素抑制剂的新型3－位具有杂原子的9－氮杂双环壬烯衍生物
AU2004233577A1 (en) * 2003-05-02 2004-11-11 Actelion Pharmaceuticals Ltd. Diazabicyclononene derivatives
WO2004105738A2 (en) * 2003-05-30 2004-12-09 Actelion Pharmaceuticals Ltd Use of tetrahydropyridine derivatives
JP2007508260A (ja) * 2003-10-09 2007-04-05 アクテリオン　ファマシューティカルズ　リミテッド 新規なテトラヒドロピリジン誘導体
CN1867568A (zh) * 2003-10-13 2006-11-22 埃科特莱茵药品有限公司 二氮杂二环壬烯衍生物及其作为血管紧张肽原酶抑制剂的用途
US20070111989A1 (en) * 2003-12-05 2007-05-17 Olivier Bezencon Novel diazabicyclononene derivatives and use
EP1705176A4 (de) * 2004-01-14 2009-06-03 Takeda Pharmaceutical Carbonsäureamidderivat und dessen anwendung
EP1729749A2 (de) * 2004-03-17 2006-12-13 Novartis AG Verwendung von renininhibitoren in therapie
AU2005276624B2 (en) 2004-08-25 2011-09-29 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
GB0428526D0 (en) * 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0504850D0 (en) * 2005-03-09 2005-04-13 Novartis Ag Organic compounds
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
NZ564689A (en) 2005-05-27 2011-02-25 Actelion Pharmaceuticals Ltd Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
WO2007049224A1 (en) * 2005-10-25 2007-05-03 Actelion Pharmaceuticals Ltd Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives
JP2009526767A (ja) 2006-02-02 2009-07-23 アクテリオン ファーマシューティカルズ リミテッド 新規二級アミン
CN101395135A (zh) * 2006-03-03 2009-03-25 埃科特莱茵药品有限公司 新颖的一级胺化物
AR059886A1 (es) * 2006-03-08 2008-05-07 Actelion Pharmaceuticals Ltd Derivados de amidas como inhibidores de renina
EP1908471A1 (de) * 2006-10-04 2008-04-09 Speedel Experimenta AG Tetrahydropyridine als Renin Inhibitoren
EP2162436A4 (de) 2007-05-24 2010-08-04 Merck Frosst Canada Ltd Neuer fall von renininhibitoren
US8334308B2 (en) 2007-08-20 2012-12-18 Merck Sharp & Dohme Corp. Renin inhibitors
JP4790871B2 (ja) 2008-05-05 2011-10-12 メルク フロスト カナダ リミテツド レニン阻害剤としての３，４−置換ピペリジン誘導体
CA2936749C (en) 2010-06-11 2019-07-09 Joshua R. Giguere Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行ｎ－脫烷反應之方法
CN117865941A (zh) * 2024-03-13 2024-04-12 上海方予健康医药科技有限公司 取代哌啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376666A (en) * 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
ATE242213T1 (de) * 1995-09-07 2003-06-15 Hoffmann La Roche Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors

Also Published As

Publication number Publication date
JP2005532371A (ja) 2005-10-27
RU2005102002A (ru) 2005-09-20
US20060009497A1 (en) 2006-01-12
PL375214A1 (en) 2005-11-28
IL165887A0 (en) 2006-01-15
TW200514772A (en) 2005-05-01
CN1662498A (zh) 2005-08-31
EP1519920A1 (de) 2005-04-06
AU2003229746A1 (en) 2004-01-19
CA2490138A1 (en) 2004-01-08
NO20050290L (no) 2005-01-19
WO2004002957A1 (en) 2004-01-08
BR0312000A (pt) 2005-03-22
CL2003002043A1 (es) 2005-01-28
MXPA04012136A (es) 2005-04-19

Similar Documents

Publication Publication Date Title
ZA200408423B (en) Novel tetrahydropyridine derivatives as renin inhibitors.
HK1093503A1 (en) Pyrido 2, 1-a-isoquinoline derivatives as ddp-IV inhibitors
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
EG25482A (en) Inhibitors
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003293356A8 (en) Dihydropyridinone derivatives as hne inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AU2003301302A1 (en) Pyradazine compounds as gsk-3 inhibitors
EP1551801A4 (de) Neue gamma-lactame als beta-sekretaseinhibitoren
AP2005003353A0 (en) Diazepinoindole derivatives as kinase inhibitors.
HK1101871A1 (en) Novel keto-oxadiazole derivatives as cathepsin inhibitors
EP1549646A4 (de) Piperidinderivate
IL162765A0 (en) Piperidine derivatives
AU2003250475A8 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003242559A1 (en) Alkylaminosiloxanes as corrosion inhibitors
AU2003244347A1 (en) Angiogenesis inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors